May 11 (Reuters) - Medical equipment maker Steris ( STE )

forecast fiscal 2027 profit above Wall Street

expectations on Monday, betting on strong demand for its

sterilization services despite narrowly missing estimates for

fourth-quarter adjusted profit.

For fiscal 2027, the company expects adjusted earnings per

share of $11.10 to $11.30, above analysts' average estimate of

$11.10, according to data compiled by LSEG. It also expects

annual revenue growth of 7% to 8%.

Steris ( STE ), which sells infection-prevention products to

hospitals and laboratories, posted a 7% rise in quarterly

revenue to $1.6 billion, helped by higher procedure volumes and

a diversified customer base. Analysts had estimated revenue of

$1.59 billion for the quarter ended March 31.

It also authorized a new $1 billion share repurchase

program.

Steris' ( STE ) fourth-quarter adjusted profit came in at $2.83 per

share, narrowly missing estimates of $2.85 per share.

Meanwhile, quarterly revenue from its largest Healthcare

segment rose 7% to $1.14 billion, while revenue from its Applied

Sterilization Technologies segment increased 6% to $289.2

million. Life Sciences revenue rose 9% to $162.9 million.